Annual report
2156.TEDINET S100R1EQ
Period2022-04-01 → 2023-03-31
Filed2023-06-26
StandardJapan GAAP
ConsolidatedYes
Data checks20 of 20 passed
Key figures · 144
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥6.3bn | 2020-04-01 → 2021-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥8.2bn | 2019-04-01 → 2020-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥8.8bn | 2018-04-01 → 2019-03-31d | Cons. | Net sales (5-year summary) |
| Operating income | ¥168m | 2022-04-01 → 2023-03-31 | Cons. | Operating income |
| Operating income | ¥60m | 2021-04-01 → 2022-03-31 | Cons. | Operating income |
| Ordinary income | ¥188m | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥76m | 2021-04-01 → 2022-03-31 | Cons. | Ordinary income |
| Ordinary income | −¥83m | 2020-04-01 → 2021-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥90m | 2019-04-01 → 2020-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥159m | 2018-04-01 → 2019-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥182m | 2022-04-01 → 2023-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥4m | 2021-04-01 → 2022-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥136m | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥25m | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥79m | 2020-04-01 → 2021-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥20m | 2019-04-01 → 2020-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥88m | 2018-04-01 → 2019-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥136m | 2022-04-01 → 2023-03-31 | Cons. | Profit loss |
| Net income | −¥25m | 2021-04-01 → 2022-03-31 | Cons. | Profit loss |
| Total assets | ¥4.2bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥4.0bn | at 2022-03-31 | Cons. | Assets |
| Total assets | ¥4.2bn | at 2021-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥4.2bn | at 2020-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥4.7bn | at 2019-03-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥2.3bn | at 2023-03-31 | Cons. | Liabilities |
| Total liabilities | ¥2.2bn | at 2022-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥1.9bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥1.7bn | at 2022-03-31 | Cons. | Net assets |
| Net assets / equity | ¥1.8bn | at 2021-03-31d | Cons. | Net assets |
| Net assets / equity | ¥1.9bn | at 2020-03-31d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥1.9bn | at 2019-03-31d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥868m | at 2023-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥701m | at 2022-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥776m | at 2023-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥606m | at 2022-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥885m | at 2021-03-31d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥811m | at 2020-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥956m | at 2019-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥265m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | −¥88m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | −¥144m | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥72m | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥211m | 2018-04-01 → 2019-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | ¥11m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | ¥47m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | ¥16m | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥26m | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥35m | 2018-04-01 → 2019-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥106m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥237m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥202m | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥191m | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥227,000 | 2018-04-01 → 2019-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥36.03 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-6.68 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-20.92 | 2020-04-01 → 2021-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥5.25 | 2019-04-01 → 2020-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥23.18 | 2018-04-01 → 2019-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥496.03 | at 2023-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥462.78 | at 2022-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥477.74 | at 2021-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥496.56 | at 2020-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥499.26 | at 2019-03-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 44.4% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 44.0% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 43.1% | at 2021-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 44.6% | at 2020-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 40.4% | at 2019-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 7.5% | 2022-04-01 → 2023-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | -1.4% | 2021-04-01 → 2022-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | -4.3% | 2020-04-01 → 2021-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 1.1% | 2019-04-01 → 2020-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 4.7% | 2018-04-01 → 2019-03-31d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 169 | at 2023-03-31 | Cons. | Number of employees |
| Employees | 167 | at 2022-03-31 | Cons. | Number of employees |
| Employees | 175 | at 2021-03-31d | Cons. | Number of employees |
| Employees | 183 | at 2020-03-31d | Cons. | Number of employees |
| Employees | 196 | at 2019-03-31d | Cons. | Number of employees |
| Revenue | ¥4.8bn | 2020-04-01 → 2021-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥6.5bn | 2019-04-01 → 2020-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥7.1bn | 2018-04-01 → 2019-03-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥54m | 2022-04-01 → 2023-03-31 | Standalone | Operating income |
| Operating income | −¥10m | 2021-04-01 → 2022-03-31 | Standalone | Operating income |
| Ordinary income | ¥82m | 2022-04-01 → 2023-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥16m | 2021-04-01 → 2022-03-31 | Standalone | Ordinary income |
| Ordinary income | −¥100m | 2020-04-01 → 2021-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥33m | 2019-04-01 → 2020-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥110m | 2018-04-01 → 2019-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥77m | 2022-04-01 → 2023-03-31 | Standalone | Income before income taxes |
| Profit before tax | −¥56m | 2021-04-01 → 2022-03-31 | Standalone | Income before income taxes |
| Net income | ¥49m | 2022-04-01 → 2023-03-31 | Standalone | Profit loss |
| Net income | −¥68m | 2021-04-01 → 2022-03-31 | Standalone | Profit loss |
| Net income | −¥96m | 2020-04-01 → 2021-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | −¥18m | 2019-04-01 → 2020-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥46m | 2018-04-01 → 2019-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥3.3bn | at 2023-03-31 | Standalone | Assets |
| Total assets | ¥3.3bn | at 2022-03-31 | Standalone | Assets |
| Total assets | ¥3.6bn | at 2021-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥3.7bn | at 2020-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥4.2bn | at 2019-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥1.8bn | at 2023-03-31 | Standalone | Liabilities |
| Total liabilities | ¥1.8bn | at 2022-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥1.6bn | at 2023-03-31 | Standalone | Net assets |
| Net assets / equity | ¥1.5bn | at 2022-03-31 | Standalone | Net assets |
| Net assets / equity | ¥1.6bn | at 2021-03-31d | Standalone | Net assets |
| Net assets / equity | ¥1.7bn | at 2020-03-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥1.8bn | at 2019-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥281m | at 2023-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥222m | at 2022-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥12.89 | 2022-04-01 → 2023-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-17.92 | 2021-04-01 → 2022-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-25.45 | 2020-04-01 → 2021-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-4.83 | 2019-04-01 → 2020-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥12.21 | 2018-04-01 → 2019-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| Dividend per share | ¥5 | 2022-04-01 → 2023-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥4 | 2021-04-01 → 2022-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥4 | 2020-04-01 → 2021-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥5 | 2019-04-01 → 2020-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥5 | 2018-04-01 → 2019-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥418.69 | at 2023-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥408.09 | at 2022-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥434.06 | at 2021-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥457.43 | at 2020-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥470.03 | at 2019-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 47.4% | at 2023-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 46.4% | at 2022-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 46.0% | at 2021-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 46.8% | at 2020-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 42.4% | at 2019-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 3.1% | 2022-04-01 → 2023-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | -4.3% | 2021-04-01 → 2022-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | -5.7% | 2020-04-01 → 2021-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | -1.1% | 2019-04-01 → 2020-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 2.6% | 2018-04-01 → 2019-03-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 6,078,000 | at 2023-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 6,078,000 | at 2022-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 6,078,000 | at 2021-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 6,078,000 | at 2020-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 6,078,000 | at 2019-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 95 | at 2023-03-31 | Standalone | Number of employees |
| Employees | 104 | at 2022-03-31 | Standalone | Number of employees |
| Employees | 112 | at 2021-03-31d | Standalone | Number of employees |
| Employees | 119 | at 2020-03-31d | Standalone | Number of employees |
| Employees | 128 | at 2019-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 36
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2023-03-31 | ¥10,000 |
| Reconciling Itemsreconciling | segment assets | at 2023-03-31 | −¥76m |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2023-03-31 | ¥2m |
| Advertising Businessreportable segment | capex | 2022-04-01 → 2023-03-31 | ¥10m |
| Advertising Businessreportable segment | depreciation | 2022-04-01 → 2023-03-31 | ¥30m |
| Advertising Businessreportable segment | employees | at 2023-03-31 | 167 pure |
| Advertising Businessreportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥2.1bn |
| Advertising Businessreportable segment | revenue intersegment | 2022-04-01 → 2023-03-31 | −¥10,000 |
| Advertising Businessreportable segment | segment assets | at 2023-03-31 | ¥4.3bn |
| Advertising Businessreportable segment | segment profit | 2022-04-01 → 2023-03-31 | ¥166m |
| Health Carereportable segment | employees | at 2023-03-31 | 2 pure |
| Health Carereportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥31m |
| Health Carereportable segment | segment assets | at 2023-03-31 | ¥37m |
| Health Carereportable segment | segment profit | 2022-04-01 → 2023-03-31 | ¥621,000 |
| Total Of Reportable Segments And Otherssegment total | capex | 2022-04-01 → 2023-03-31 | ¥10m |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2022-04-01 → 2023-03-31 | ¥30m |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2023-03-31 | ¥2.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-04-01 → 2023-03-31 | −¥10,000 |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2023-03-31 | ¥4.3bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2023-03-31 | ¥166m |
| Reconciling Itemsreconciling | segment assets | at 2022-03-31 | −¥71m |
| Reconciling Itemsreconciling | segment profit | 2021-04-01 → 2022-03-31 | ¥2m |
| Advertising Businessreportable segment | capex | 2021-04-01 → 2022-03-31 | ¥7m |
| Advertising Businessreportable segment | depreciation | 2021-04-01 → 2022-03-31 | ¥34m |
| Advertising Businessreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥1.9bn |
| Advertising Businessreportable segment | segment assets | at 2022-03-31 | ¥4.0bn |
| Advertising Businessreportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥58m |
| Health Carereportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥29m |
| Health Carereportable segment | segment assets | at 2022-03-31 | ¥31m |
| Health Carereportable segment | segment profit | 2021-04-01 → 2022-03-31 | −¥656,000 |
| Total Of Reportable Segments And Otherssegment total | capex | 2021-04-01 → 2022-03-31 | ¥7m |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2021-04-01 → 2022-03-31 | ¥34m |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-04-01 → 2022-03-31 | ¥1.9bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2022-03-31 | ¥4.0bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-04-01 → 2022-03-31 | ¥58m |
| Advertising Businessreportable segment | employees | at 2023-03-31 | 95 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,492
| Item | Context | Value | Unit |
|---|---|---|---|
| Repayment of long term loans payable fin cf | CurrentYearDuration | -158076000 | JPY |
| Proceeds from issuance of bonds fin cf | Prior1YearDuration | － | JPY |
| Proceeds from issuance of bonds fin cf | CurrentYearDuration | 100000000 | JPY |
| Redemption of bonds fin cf | Prior1YearDuration | － | JPY |
| Redemption of bonds fin cf | CurrentYearDuration | -150000000 | JPY |
| Cash dividends paid fin cf | Prior1YearDuration | -15110000 | JPY |
| Cash dividends paid fin cf | CurrentYearDuration | -15110000 | JPY |
| Other net fin cf | Prior1YearDuration | -2712000 | JPY |
| Other net fin cf | CurrentYearDuration | -2118000 | JPY |
| Net cash provided by used in financing activities | Prior1YearDuration | -237401000 | JPY |
| Net cash provided by used in financing activities | CurrentYearDuration | -106304000 | JPY |
| Net increase decrease in cash and cash equivalents | Prior1YearDuration | -278898000 | JPY |
| Net increase decrease in cash and cash equivalents | CurrentYearDuration | 170237000 | JPY |
| Cash and cash equivalents | Prior2YearInstant | 885158000 | JPY |
| Cash and cash equivalents | Prior1YearInstant | 606260000 | JPY |
| Cash and cash equivalents | Prior1YearInstant | 606260000 | JPY |
| Cash and cash equivalents | CurrentYearInstant | 776497000 | JPY |
| Number of consolidated subsidiaries | CurrentYearInstant | 7 | |
| Number of associates accounted for using equity method | CurrentYearInstant | － | |
| Discounted trade notes receivable | Prior1YearInstant | 5415000 | JPY |
| Discounted trade notes receivable | CurrentYearInstant | 3494000 | JPY |
| Compensations salaries and allowances sga | Prior1YearDuration | 781501000 | JPY |
| Compensations salaries and allowances sga | CurrentYearDuration | 806072000 | JPY |
| Provision for bonuses sga | Prior1YearDuration | 37108000 | JPY |
| Provision for bonuses sga | CurrentYearDuration | 54913000 | JPY |
| Retirement benefit expenses sga | Prior1YearDuration | 21762000 | JPY |
| Retirement benefit expenses sga | CurrentYearDuration | 21387000 | JPY |
| Provision for directors retirement benefits sga | Prior1YearDuration | 750000 | JPY |
| Provision for directors retirement benefits sga | CurrentYearDuration | 750000 | JPY |
| Provision of allowance for doubtful accounts sga | Prior1YearDuration | -2498000 | JPY |
| Provision of allowance for doubtful accounts sga | CurrentYearDuration | -9000 | JPY |
| Revenues from external customers | Prior1YearDuration_jpcrp030000-asr_E05701-000AdvertisingBusinessReportableSegmentsMember | 1909506000 | JPY |
| Revenues from external customers | Prior1YearDuration_jpcrp030000-asr_E05701-000HealthCareReportableSegmentsMember | 29287000 | JPY |
| Revenues from external customers | Prior1YearDuration_TotalOfReportableSegmentsAndOthersMember | 1938793000 | JPY |
| Revenues from external customers | Prior1YearDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | Prior1YearDuration | 1938793000 | JPY |
| Transactions with other segments | Prior1YearDuration_jpcrp030000-asr_E05701-000AdvertisingBusinessReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YearDuration_jpcrp030000-asr_E05701-000HealthCareReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YearDuration_TotalOfReportableSegmentsAndOthersMember | － | JPY |
| Transactions with other segments | Prior1YearDuration_ReconcilingItemsMember | － | JPY |
| Transactions with other segments | Prior1YearDuration | － | JPY |
| Proceeds | Prior1YearDuration_jpcrp030000-asr_E05701-000AdvertisingBusinessReportableSegmentsMember | 1909506000 | JPY |
| Proceeds | Prior1YearDuration_jpcrp030000-asr_E05701-000HealthCareReportableSegmentsMember | 29287000 | JPY |
| Proceeds | Prior1YearDuration_TotalOfReportableSegmentsAndOthersMember | 1938793000 | JPY |
| Proceeds | Prior1YearDuration_ReconcilingItemsMember | － | JPY |
| Proceeds | Prior1YearDuration | 1938793000 | JPY |
| Operating income | Prior1YearDuration_jpcrp030000-asr_E05701-000AdvertisingBusinessReportableSegmentsMember | 58409000 | JPY |
| Operating income | Prior1YearDuration_jpcrp030000-asr_E05701-000HealthCareReportableSegmentsMember | -656000 | JPY |
| Operating income | Prior1YearDuration_TotalOfReportableSegmentsAndOthersMember | 57753000 | JPY |
| Operating income | Prior1YearDuration_ReconcilingItemsMember | 1800000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 20 of 20 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |